Siemens is first distributor of Rcadia’s cardiac assessment technology
This article was originally published in Clinica
Rcadia Medical Imaging has snapped up Siemens Healthcare as a partner in its maiden distribution deal for its COR Analyzer system. The FDA-approved and CE-marked device will be distributed by Siemens on a non-exclusive basis in the US, UK, Germany and Australia. Rcadia (Auburndale, Massachusetts) has sold a minimal amount of units themselves in the US, but told Clinica that it had always planned to team up with one of the big imaging players. The firm expects the deal to result in “substantial sales” for the product. Under the terms of the agreement, Siemens will offer the COR Analyzer as part of its Syngo.via visualisation software for evaluating suspected coronary artery disease patients. The COR Analyzer is designed to identify stenotic lesions using coronary computed tomography angiography. Siemens’ Syngo.via software is used to automate imaging procedures using computed tomography, magnetic resonance, CT and PET imaging technology in the fields of cardiology, oncology and neurology.
You may also be interested in...
Alere’s professional diagnostics business helped the firm record overall revenue growth in the fourth quarter of 2010, offsetting a fall in influenza-based sales in North America.
Integra LifeSciences has gained exclusive worldwide rights from Stout Medical to develop and commercialise an expandable interbody fusion device.
Gen-Probe recently launched its Panther automated molecular diagnostics system in Europe with the aim of bringing another dimension to its product portfolio. Joseph Harvey met the firm’s CEO, Carl Hull, at the launch of the product in Frankfurt to find how high the firm has set its sights in the molecular diagnostics sector and how it is going to achieve its goals